Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group
AAT were not associated with EOI MRD positivity.
Understanding that asparaginase-associated toxicities do not worsen early‑induction minimal residual disease adds confidence that intensifying monitoring or prophylaxis can be pursued without compromising therapeutic efficacy.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- Acute Myeloid Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
- Recent advances on blinatumomab for acute lymphoblastic leukemia
- NCT05800210: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
- Advancing the Diagnosis of Non‑Hodgkin Lymphoma Through Next‑Generation Sequencing in Developing Countries: An Evaluation of Progress — A Narrative Review
- Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)